DeepMed Research

DARTMOUTH-HITCHCOCK MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1983-01-01

Employees: 10K

Market Cap: -

Website: http://www.dartmouth-hitchcock.org

Clinical Trials

Protocol to Obtain Blood and Bone Marrow Samples for Myeloma Research

Terminated

Conditions: Multiple Myeloma

First Posted Date: 2011-06-27

Last Posted Date: 2018-04-25

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 29

Registration Number: NCT01382615

Locations: 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

Effect of Ketoconazole on Breathlessness

Phase 4

Completed

Conditions: Chronic Obstructive Pulmonary Disease

Interventions: Drug: ketoconazole
Drug: inert powder

First Posted Date: 2011-06-22

Last Posted Date: 2018-06-01

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 20

Registration Number: NCT01378520

Locations: 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

Helping Patients With Spinal Stenosis Make a Treatment Decision: A Randomized Study Assessing The Benefits of Health Coaching

Not Applicable

Completed

Conditions: Spinal Stenosis

Interventions: Other: Usual Care
Behavioral: Coaching

First Posted Date: 2010-12-21

Last Posted Date: 2013-08-05

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 199

Registration Number: NCT01263678

Locations: 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

Study of Palliative Care Intervention for Advanced Cancer Patients and Their Caregivers -Educate Nurture Advise Before Life Ends (ENABLE III)

Not Applicable

Completed

Conditions: Advanced Cancer

Interventions: Behavioral: Early palliative care intervention
Behavioral: Later entry group

First Posted Date: 2010-11-22

Last Posted Date: 2014-01-03

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 360

Registration Number: NCT01245621

Locations: 🇺🇸
Providence VA Medical Center, Providence, Rhode Island, United States
🇺🇸
Dartmouth-Hitchcock Medical Center - Lebanon, Lebanon, New Hampshire, United States
🇺🇸
Dartmouth-Hitchcock Clinic - Manchester, Manchester, New Hampshire, United States

and more 4 locations

Bendamustine and Rituximab Followed by 90-yttrium (Y) Ibritumomab Tiuxetan for Untreated Follicular Lymphoma

Phase 2

Completed

Conditions: Lymphoma, Follicular

Interventions: Drug: Bendamustine
Drug: Rituximab
Radiation: Y-90 ibritumomab

First Posted Date: 2010-11-04

Last Posted Date: 2021-05-18

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 39

Registration Number: NCT01234766

Locations: 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
🇺🇸
Maine Center for Cancer Medicine, Scarborough, Maine, United States
🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

and more 1 locations

Participation Restrictions in Breast Cancer Survivors

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Behavioral: Behavioral activation/problem-solving (BA/PS)

First Posted Date: 2010-10-21

Last Posted Date: 2014-12-19

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 24

Registration Number: NCT01225328

Locations: 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

A Study of Quetiapine and Mirtazapine for the Treatment of Alcohol Dependency

Phase 2

Completed

Conditions: Alcohol Dependence

Interventions: Drug: Quetiapine fumarate extended release (Quetiapine XR)
Drug: Mirtazapine

First Posted Date: 2010-07-20

Last Posted Date: 2018-04-09

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 20

Registration Number: NCT01165541

Locations: 🇺🇸
Dartmouth Medical School Department of Psychiatry's Addition Research Center, Bedford, New Hampshire, United States
🇺🇸
Dartmouth Medical School Department of Psychiatry's Addiction Research Center, Hanover, New Hampshire, United States

Erlotinib (Tarceva) and Bexarotene (Targretin) Oral Capsules in Advanced Cancers of the Aerodigestive Tract

Phase 1

Completed

Conditions: Advanced, Malignant Aerodigestive Tract Tumor (Lung, Head and Neck and Esophagus)

Interventions: Drug: Bexarotene (Targretin®)
Drug: Erlotinib (Tarceva™)

First Posted Date: 2010-05-05

Last Posted Date: 2023-10-18

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 24

Registration Number: NCT01116622

Locations: 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

The Neuroeconomics of Behavioral Therapies for Adolescent Substance Abuse

Completed

Conditions: Adolescent Substance Use

First Posted Date: 2010-03-26

Last Posted Date: 2018-03-19

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 51

Registration Number: NCT01093898

Locations: 🇺🇸
Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, United States

Exploratory Study of the Modulation of the Immune System by VEGF Blockade in Patients With Glioblastoma Multiforme (GBM)

Early Phase 1

Completed

Conditions: Glioblastoma Multiforme

Interventions: Drug: Bevacizumab

First Posted Date: 2010-03-24

Last Posted Date: 2018-05-25

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 13

Registration Number: NCT01091792

Locations: 🇺🇸
Dartmouth Hithcock Medcial Center, Lebanon, New Hampshire, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy